DILIGENTRESPOND
LIVE

Serial Number

99151196

Owner

Diligent Pharma, Inc.

Attorney

Harris A. Wolin

First Use Date

Dec 31, 2025

Filing Date

Apr 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DILIGENTRESPOND Trademark

Serial Number: 99151196 • Registration: 8338781

DILIGENTRESPOND is a trademark filed by Diligent Pharma, Inc. on April 23, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Diligent Pharma, Inc.

179 Nassau St., Suite 3A
Princeton, NJ 08542

Entity Type: 03

Trademark Details

Filing Date

April 23, 2025

Registration Date

July 7, 2026

First Use Anywhere

December 31, 2025

First Use in Commerce

December 31, 2025

Published for Opposition

October 28, 2025

Goods & Services

Technical consulting in the field of pharmaceutical studies; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Consulting services in the field of providing online, non-downloadable software and applications; Providing temporary use of on-line non-downloadable software and applications for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices by analyzing audit data, providing access to a database of vendors, including investigational study sites, and a search engine for database content, managing vendors and investigational study site contacts and regulatory compliance qualifications and bids; Providing on-line non-downloadable software for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices by analyzing audit data, providing access to a database of vendors, including investigational study sites, and a search engine for database content, managing vendors and investigational study site contacts and regulatory compliance qualifications and bids; Providing temporary use of on-line non-downloadable software for clinical trial vendor and selection and management

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 7, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 18, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 18, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2026 CRFA
ASSIGNED TO LIE
Jun 18, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 9, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 9, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 20, 2026 SUPC
USE AMENDMENT FILED
Jan 15, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 15, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 23, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 25, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 25, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 25, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 25, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 23, 2025 MAFR
NEW APPLICATION ENTERED
Apr 23, 2025 NWAP